Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform

• প্রধান লেখক: Tatiana Karelina (লেখক), Stepan Lerner (লেখক), Alexandr Stepanov (লেখক), Mark Meerson (লেখক), Oleg Demin (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Wiley, 2021-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract For many years, clinical research in Alzheimer's disease (AD) has focused on attempts to identify the most explicit biomarker, namely amyloid beta. Unfortunately, the numerous therapies that have been developed have failed in clinical practice. AD arises as a consequence of multiple fa...